WAX — Wam Research Balance Sheet
0.000.00%
- AU$256.77m
- AU$22.96m
- AU$6.01m
- 78
- 77
- 67
- 85
Annual balance sheet for Wam Research, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 248 | 183 | 184 | 218 | 234 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.28 | 3.3 | 4.72 | 3.51 | 1.7 |
Total Current Assets | 250 | 186 | 189 | 221 | 236 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 264 | 205 | 204 | 234 | 243 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18.4 | 5.68 | 4.43 | 16.9 | 13 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Liabilities | 27.9 | 5.68 | 4.43 | 19 | 17.1 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 236 | 199 | 199 | 215 | 226 |
Total Liabilities & Shareholders' Equity | 264 | 205 | 204 | 234 | 243 |
Total Common Shares Outstanding |